Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance

Nature Reviews Genetics

Volumn 14, Issue 4, 2013, Pages 243-248

  Palmer, Adam C ^a   Kishony, Roy ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; FLUORESCENT DYE; RIFAMPICIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DNA BARCODING; DRUG RESISTANCE; FLOW CYTOMETRY; GENE EXPRESSION; GENE FREQUENCY; GENE LIBRARY; GENE MUTATION; GENE SEQUENCE; GENE TRANSFER; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENOME; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HORIZONTAL GENE TRANSFER; HUMAN; MOLECULAR CLONING; MONOTHERAPY; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENETIC TREE; PRIORITY JOURNAL; STOCHASTIC MODEL; TUBERCULOSIS; TURBIDIMETRY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DIRECTED MOLECULAR EVOLUTION; DRUG RESISTANCE, MICROBIAL; GENOMICS; GENOTYPE; HUMANS; PHYLOGENY;

BACTERIA (MICROORGANISMS);

EID: 84875212396     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg3351     Document Type: Article

References (50)

1. World Health Organization. The evolving threat of antimicrobial resistance: options for action (World Health Organization, 2012).
2. Paterson, D. L. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am. J. Med. 119, S20-S28; discussion S62-S70 (2006).
3. Didelot, X., Bowden, R., Wilson, D. J., Peto, T. E. & Crook, D. W. Transforming clinical microbiology with bacterial genome sequencing. Nature Rev. Genet. 13, 601-612 (2012).
4. Morar, M. & Wright, G. D. The genomic enzymology of antibiotic resistance. Annu. Rev. Genet. 44, 25-51 (2010).
5. Novais, A. et al. Evolutionary trajectories of ?-lactamase CTX?M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog. 6, e1000735 (2010).
6. Elena, S. F. & Lenski, R. E. Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nature Rev. Genet. 4, 457-469 (2003).
7. Toprak, E. et al. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nature Genet. 44, 101-105 (2012).
8. Lee, H. H., Molla, M. N., Cantor, C. R. & Collins, J. J. Bacterial charity work leads to population-wide resistance. Nature 467, 82-85 (2010).
9. Zhang, Q. et al. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science 333, 1764-1767 (2011).
10. Torella, J. P., Chait, R. & Kishony, R. Optimal drug synergy in antimicrobial treatments. PLoS Comput. Biol. 6, e1000796 (2010).
11. Bonhoeffer, S., Lipsitch, M. & Levin, B. R. Evaluating treatment protocols to prevent antibiotic resistance. Proc. Natl Acad. Sci. USA 94, 12106-12111 (1997).
12. Michel, J. B., Yeh, P. J., Chait, R., Moellering, R. C. Jr & Kishony, R. Drug interactions modulate the potential for evolution of resistance Proc. Natl Acad. Sci. USA 2008.;105:14918-14923
13. Hegreness, M., Shoresh, N., Damian, D., Hartl, D. & Kishony, R. Accelerated evolution of resistance in multidrug environments. Proc. Natl Acad. Sci. USA 105, 13977-13981 (2008).
14. Chait, R., Craney, A. & Kishony, R. Antibiotic interactions that select against resistance. Nature 446, 668-671 (2007).
15. Palmer, A. C., Angelino, E. & Kishony, R. Chemical decay of an antibiotic inverts selection for resistance. Nature Chem. Biol. 6, 105-107 (2010).
16. Yeh, P. J., Hegreness, M. J., Aiden, A. P. & Kishony, R. Drug interactions and the evolution of antibiotic resistance. Nature Rev. Microbiol. 7, 460-466 (2009).
17. Mwangi, M. M. et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl Acad. Sci. USA 104, 9451-9456 (2007).
18. Lieberman, T. D. et al. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nature Genet. 43, 1275-1280 (2011).
19. Comas, I. et al. Whole-genome sequencing of rifampicinresistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nature Genet. 44, 106-110 (2012).
20. Harris, S. R. et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327, 469-474 (2010).
21. Croucher, N. J. et al. Rapid pneumococcal evolution in response to clinical interventions. Science 331, 430-434 (2011).
22. Baldauf, S. L. Phylogeny for the faint of heart: a tutorial. Trends Genet. 19, 345-351 (2003).
23. Didelot, X. & Falush, D. Inference of bacterial microevolution using multilocus sequence data. Genetics 175, 1251-1266 (2007).
24. Cohen, T. & Murray, M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nature Med. 10, 1117-1121 (2004).
25. Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nature Rev. Microbiol. 8, 260-271 (2010).
26. Hegreness, M., Shoresh, N., Hartl, D. & Kishony, R. An equivalence principle for the incorporation of favorable mutations in asexual populations. Science 311, 1615-1617 (2006).
27. Chubiz, L. M., Lee, M. C., Delaney, N. F. & Marx, C. J. FREQ-seq: a rapid, cost-effective, sequencing-based method to determine allele frequencies directly from mixed populations. PLoS ONE 7, e47959 (2012).
28. Levin-Reisman, I. et al. Automated imaging with ScanLag reveals previously undetectable bacterial growth phenotypes. Nature Methods 7, 737-739 (2010).
29. Goodarzi, H., Hottes, A. K. & Tavazoie, S. Global discovery of adaptive mutations. Nature Methods 6, 581-583 (2009).
30. Schenk, M. F., Szendro, I. G., Krug, J. & de Visser, J. A. Quantifying the adaptive potential of an antibiotic resistance enzyme. PLoS Genet. 8, e1002783 (2012).
31. Salverda, M. L. et al. Initial mutations direct alternative pathways of protein evolution. PLoS Genet. 7, e1001321 (2011).
32. van Opijnen, T., Bodi, K. L. & Camilli, A. Tn?seq: highthroughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nature Methods 6, 767-772 (2009).
33. Girgis, H. S., Hottes, A. K. & Tavazoie, S. Genetic architecture of intrinsic antibiotic susceptibility. PLoS ONE 4, e5629 (2009).
34. Poelwijk, F. J., Kiviet, D. J., Weinreich, D. M. & Tans, S. J. Empirical fitness landscapes reveal accessible evolutionary paths. Nature 445, 383-386 (2007).
35. Weinreich, D. M., Delaney, N. F., Depristo, M. A. & Hartl, D. L. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312, 111-114 (2006).
36. Lozovsky, E. R. et al. Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc. Natl Acad. Sci. USA 106, 12025-12030 (2009).
37. Tan, L., Serene, S., Chao, H. X. & Gore, J. Hidden randomness between fitness landscapes limits reverse evolution. Phys. Rev. Lett. 106, 198102 (2011).
38. Trindade, S. et al. Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet. 5, e1000578 (2009).
39. Brown, K. M. et al. Compensatory mutations restore fitness during the evolution of dihydrofolate reductase. Mol. Biol. Evol. 27, 2682-2690 (2010).
40. Hall, A. R. & MacLean, R. C. Epistasis buffers the fitness effects of rifampicin-resistance mutations in Pseudomonas aeruginosa. Evolution 65, 2370-2379 (2011).
41. D'Costa, V. M., McGrann, K. M., Hughes, D. W. & Wright, G. D. Sampling the antibiotic resistome. Science 311, 374-377 (2006).
42. Sommer, M. O., Church, G. M. & Dantas, G. The human microbiome harbors a diverse reservoir of antibiotic resistance genes. Virulence 1, 299-303 (2010).
43. D'Costa, V. M. et al. Antibiotic resistance is ancient. Nature 477, 457-461 (2011).
44. Riesenfeld, C. S., Goodman, R. M. & Handelsman, J. Uncultured soil bacteria are a reservoir of new antibiotic resistance genes. Environ. Microbiol. 6, 981-989 (2004).
45. D'Costa, V. M. et al. Inactivation of the lipopeptide antibiotic daptomycin by hydrolytic mechanisms. Antimicrob. Agents Chemother. 56, 757-764 (2012).
46. Chusri, S., Villanueva, I., Voravuthikunchai, S. P. & Davies, J. Enhancing antibiotic activity: a strategy to control Acinetobacter infections. J. Antimicrob. Chemother. 64, 1203-1211 (2009).
47. Lewis, K. Antibiotics: recover the lost art of drug discovery. Nature 485, 439-440 (2012).
48. Koser, C. U. et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N. Engl. J. Med. 366, 2267-2275 (2012).
49. Snitkin, E. S. et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci. Transl. Med. 4, 148ra116 (2012).
50. Harris, S. R. et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect. Dis. 13, 130-136 (2012).